Bavarian Nordic
Danish vaccine manufacturing company
BAVA Nasdaq Copenhagen · home listing
BVNRY OTC Markets Group
ISIN DK0015998017 LEI 2138006JCDVYIN6INP51
Follow Bavarian Nordic
Weekly email: filings, results
Revenue, last year
DKK 6.2B
Net income
DKK 1.4B
EPS, diluted
DKK 17.60
Operating cash flow
DKK 2.7B
Source: ESEF annual reports · latest filing